Shares of Envision Healthcare Co. (NYSE:EVHC) have earned an average recommendation of “Buy” from the sixteen analysts that are presently covering the company. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation, ten have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $75.86.
Several analysts have recently issued reports on the company. Cantor Fitzgerald reaffirmed a “buy” rating and set a $80.00 price objective on shares of Envision Healthcare in a report on Thursday, April 6th. Jefferies Group LLC reaffirmed a “buy” rating and set a $82.00 price objective (down from $90.00) on shares of Envision Healthcare in a report on Wednesday, March 1st. Canaccord Genuity reaffirmed a “buy” rating and set a $86.00 price objective on shares of Envision Healthcare in a report on Tuesday. Royal Bank of Canada decreased their price objective on Envision Healthcare from $87.00 to $80.00 and set an “outperform” rating on the stock in a report on Wednesday, March 1st. Finally, Zacks Investment Research raised Envision Healthcare from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a report on Wednesday, February 1st.
In related news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $65.00, for a total transaction of $97,500.00. Following the sale, the insider now owns 104,319 shares in the company, valued at approximately $6,780,735. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 2.30% of the company’s stock.
A number of institutional investors have recently made changes to their positions in EVHC. Morgan Stanley increased its position in shares of Envision Healthcare by 506.4% in the third quarter. Morgan Stanley now owns 6,715,363 shares of the company’s stock valued at $149,551,000 after buying an additional 5,608,016 shares during the period. Valinor Management L.P. increased its position in shares of Envision Healthcare by 16.6% in the third quarter. Valinor Management L.P. now owns 5,234,911 shares of the company’s stock valued at $116,582,000 after buying an additional 746,888 shares during the period. BlackRock Institutional Trust Company N.A. increased its position in shares of Envision Healthcare by 1.2% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 4,925,792 shares of the company’s stock valued at $109,697,000 after buying an additional 58,376 shares during the period. Artisan Partners Limited Partnership increased its position in shares of Envision Healthcare by 42.6% in the fourth quarter. Artisan Partners Limited Partnership now owns 3,958,470 shares of the company’s stock valued at $250,532,000 after buying an additional 1,182,329 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in shares of Envision Healthcare by 160.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,835,274 shares of the company’s stock valued at $179,458,000 after buying an additional 1,747,904 shares during the period. 35.96% of the stock is currently owned by institutional investors.
Shares of Envision Healthcare (NYSE:EVHC) traded down 3.60% on Tuesday, hitting $55.39. 4,567,366 shares of the stock were exchanged. Envision Healthcare has a 52-week low of $53.12 and a 52-week high of $83.27. The company’s market cap is $6.44 billion. The company has a 50 day moving average of $62.93 and a 200 day moving average of $52.16.
Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings results on Tuesday, February 28th. The company reported $1.08 EPS for the quarter, missing the Zacks’ consensus estimate of $1.20 by $0.12. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. The business earned $1.39 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same period in the prior year, the firm posted $1.07 earnings per share. The firm’s revenue for the quarter was up 97.4% on a year-over-year basis. Equities research analysts forecast that Envision Healthcare will post $1.40 earnings per share for the current year.
About Envision Healthcare
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with MarketBeat.com's FREE daily email newsletter.